22.71 M
About MagForce AG
Sector
Industry
CEO
Benjamin J. Lipps
Website
Headquarters
Berlin
Founded
2000
ISIN
DE000A0HGQF5
FIGI
BBG000TFF6L1
MagForce AG engages in the development and distribution of a nanotechnology based cancer therapy. It offers Nanotherm therapy, which includes a liquid containing iron oxide nanoparticles that interact with an alternating magnetic field to destroy cancer cells, as well as an application, in which the progress of the therapy can be planned and documented. The company was founded in 1997 and is headquartered in Berlin, Germany.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on HAM exchange MagForce AG stocks are traded under the ticker MF6.
Yes, you can track MagForce AG financials in yearly and quarterly reports right on TradingView.
No, MF6 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MF6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MagForce AG stock right from TradingView charts — choose your broker and connect to your account.